Registro:

Referencias:

• Truman, J.W., Steroid receptors and nervous system metamorphosis in insects (1996) Dev. Neurosci, 18 (1-2), pp. 87-101
• Subramoniam, T., Crustacean ecdysteriods in reproduction and embryogenesis (2000) Comp. Biochem. Physiol. C, Pharmacol. Toxicol Endocrinol, 125, pp. 135-156
• Lydon, J.P., Demayo, F.J., Funk, C.R., Mani, S.K., Hughes, A.R., Montgomery, C.A., Shyamala, G., O'Malley, B.W., Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities (1995) Genes Dev, 9, pp. 2266-2278
• Liu, D., Dillon, J.S., Dehydroepiandrosterone stimulates nitric oxide release in vascular endothelial cells: Evidence for a cell surface receptor (2004) Steroids, 69, pp. 279-289
• Stahn, C., Löwenberg, M., Hommes, D.W., Buttgereit, F., Molecular mechanisms of glucocorticoid action and selective glucocorticoid receptor agonists (2007) Mol. Cell Endocrinol, 275, pp. 71-78
• Thomas, P., Characteristics of membrane progestin receptor alpha (mPRalpha) and progesterone membrane receptor component 1 (PGMRC1) and their roles in mediating rapid progestin actions (2008) Front Neuroendocrinol, 29, pp. 292-312
• White, H.D., Crassi, K.M., Givan, A.L., Stern, J.E., Gonzalez, J.L., Memoli, V.A., Green, W.R., Wira, C.R., CD3+ CD8+ CTL activity within the human female reproductive tract: Influence of stage of the menstrual cycle and menopause (1997) J. Immunol, 158, pp. 3017-3027
• Miller, L., Hunt, J.S., Regulation of TNF-a production in activated mouse macrophages by progesterone (1998) J. Immunol, 160, pp. 5098-5104
• Muñoz, L.D., Serramía, M.J., Fresno, M., Muñoz-Fernández, M.A., Progesterone inhibits HIV-1 replication in human trophoblast cells through inhibition of autocrine tumor necrosis factor secretion (2007) J. Infect. Dis, 195, pp. 1294-1302
• Asin, S.N., Heimberg, A.M., Eszterhas, S.K., Rollenhagen, C., Howell, A.L., Estradiol and progesterone regulate HIV type 1 replication in peripheral blood cells (2008) AIDS Res. Hum. Retroviruses, 24, pp. 701-716
• Björnström, L., Sjöberg, M., Mechanisms of estrogen receptor signaling: Convergence of genomic and nongenomic actions on target genes (2005) Mol. Endocrinol, 19, pp. 833-842
• Trunova, N., Tsai, L., Tung, S., Schneider, E., Harouse, J., Gettie, A., Simon, V., Cheng-Mayer, C., Progestin-based contraceptive suppresses cellular immune responses in SHIV- infected rhesus macaques (2006) Virology, 352, pp. 169-177
• Genescà, M., Li, J., Fritts, L., Chohan, P., Bost, K., Rourke, T., Blozis, S.A., Miller, C.J., Depo-Provera abrogates attenuated lentivirus-induced protection in male rhesus macaques challenged intravenously with pathogenic SIVmac239 (2007) J. Med. Primatol, 36, pp. 266-275
• Morrison, C.S., Richardson, B.A., Mmiro, F., Chipato, T., Celentano, D.D., Luoto, J., Mugerwa, R., Salata, R.A., Hormonal contraception and the risk of HIV acquisition (2007) AIDS, 2, pp. 85-95
• Baeten, J.M., Benki, S., Chohan, V., Lavreys, L., McClelland, R.S., Mandaliya, K., Ndinya-Achola, J.O., Overbaugh, J., Hormonal contraceptive use, herpes simplex virus infection, and risk of HIV-1 acquisition among Kenyan women (2007) AIDS, 21, pp. 1771-1777
• Hughes, G.C., Thomas, S., Li, C., Kaja, M.K., Clark, E.A., Cutting edge: Progesterone regulates IFN-alpha production by plasmacytoid dendritic cells (2008) J. Immunol, 180, pp. 2029-2033
• Myer, L., Wright, T.C., Kuhu, L., Prospective study of hormonal contraception and women's risk of HIV infection in South Africa (2007) Int. J. Epidemiol, 36, pp. 166-174
• Kaushic, C., Ashkar, A.A., Reid, L.A., Rosenthla, K.L., Progesterone Increases susceptibility and decreases Immune responses to genital herpes infection (2003) J. Virol, 77, pp. 4558-4565
• Petrera, E., Joselevich, M., Ghini, A., Burton, G., Coto, C.E., Anti-herpes virus activities of new 6-19 carbon-bridged steroids and some synthetic precursors (2003) Antivir Chem. Chemother, 14, pp. 243-248
• Lancz, G., Whitaker-Dowling, P., Marsh, Y.V., Bradley, G., Eppstein, D.A., Hackney, J.F., Hulick-Swardstrom, B., Inhibition of vesicular stomatitis virus replication in dexamethasone-treated L929 cells (1990) Proc. Soc. Exp. Biol. Med, 193, pp. 190-196
• Suzuki, T., Yamaya, M., Sekizawa, K., Yamada, N., Nakayama, K., Ishizuka, S., Kamanaka, M., Sasaki, H., Effects of dexamethasone on rhinovirus infection in cultured human tracheal epithelial cells (2000) Am. J. Physiol. Lung Cell Mol. Physiol, 278, pp. 560-571
• Farr, B.M., Gwaltney Jr., J.M., Hendley, J.O., Hayden, F.G., Naclerio, R.M., McBride, T., Doyle, W.J., Proud, D.A., Randomized controlled trial of glucocor-ticoid prophylaxis against experimental rhinovirus infection (1990) J. Infect. Dis, 162, pp. 1173-1177
• Grünberg, K., Sharon, R.F., Sont, J.K., In 't Veen, J.C., Van Schadewijk, W.A., De Klerk, E.P., Dick, C.R., Sterk, P.J., Rhinovirus-induced Airway Inflammation In Asthma: Effect of Treatment With Inhaled Corticosteroids Before and During Experimental Infection (2001) Am. J. Respir. Crit. Care Med, 164, pp. 1816-1822
• Kimsey, P.B., Goad, M.E., Zhao, Z.B., Brackee, G., Fox, J.G., Methyl prednisolone acetate modulation of infection and subsequent pulmonary pathology in hamsters exposed to parainfluenza-1 virus (Sendai) (1989) Am. Rev. Respir. Dis, 140, pp. 1704-1711
• Moreno, L., Jacoby, D.B., Fryer, A.D., Dexamethasone prevents virus-induced hyperresponsiveness via multiple mechanisms (2003) Am. J. Physiol. Lung Cell Mol. Physiol, 285, pp. 451-455
• Kargel, M.J., Lapinsky, S.E., Pro/con clinical debate: Steroids are a key component in the treatment of SARS. Con: No, steroids are not a key component of the treatment regimen for SARS (2004) Crit. Care, 8, pp. 105-107
• Lee, N., Hui, D., Wu, A., Chan, P., Cameron, P., Joynt, G.M., Ahuja, A., Sung, J.J.A., Major outbreak of severe acute respiratory syndrome in Hong Kong (2003) N. Engl. J. Med, 348, pp. 1986-1994
• Drosten, C., Günther, S., Preiser, W., van der Werf, S., Brodt, H.R., Becker, S., Rabenau, H., Doerr, H.W., Identification of a novel coronavirus in patients with severe acute respiratory syndrome (2003) N. Engl. J. Med, 348, pp. 1967-1976
• Sung, J.J., Wu, A., Joynt, G.M., Yuen, K.Y., Lee, N., Chan, P.K., Cockram, C.S., Hui, D.S., Severe acute respiratory syndrome: Report of treatment and out-come after a major outbreak (2004) Thorax, 59, pp. 414-420
• Tai, D.Y.H., Pharmacologic treatment of SARS: Current knowledge and recommendations (2007) Ann. Acad. Med. Singapore, 36, pp. 438-443
• Knowles, S.R., Phillips, E.J., Dresser, L., Matukas, L., Common adverse events associated with the use of ribavirin for severe acute respiratory syndrome in Canada (2003) Clin. Infect. Dis, 37, pp. 1139-1142
• Muller, M.P., Dresser, L., Raboud, J., McGeer, A., Rea, E., Richardson, S.E., Mazzulli, T., Canadian, S.A.R.S., Research Network. Adverse events associated with high-dose ribavirin: Evidence from the Toronto outbreak of severe acute respiratory syndrome (2007) Pharmacotherapy, 27, pp. 494-503
• Chen, S.H., Yao, H.W., Huang, W.Y., Hsu, K.S., Lei, H.Y., Shiau, A.L., Chen, S.H., Efficient reactivation of latent herpes simplex virus from mouse central nervous system tissues (2006) J. Virol, 80, pp. 12387-12392
• Dreyer, L.L., Sydiskis, R.J., Bashirelahi, N., Effect of dexametha-sone on herpes simplex virus replication in mouse neuroblastoma cells (NB41A3): Receptor characteristics (1989) J. Clin. Lab. Anal, 3, pp. 236-243
• Hato, N., Murakami, S., Gyo, K., Steroid and antiviral treatment for Bell's palsy (2008) Lancet, 371, pp. 1818-1820
• Furuta, Y., Fukuda, S., Chida, E., Takasu, T., Otan, F., Inuyama, Y., Nagashima, K., Reactivation of herpes simplex virus type 1 in patients with Bell'palsy (1998) J. Med. Virol, 54, pp. 162-166
• Hato, N., Yamada, H., Cono, H., Matsumoto, S., Honda, N., Gyo, K., Fukuda, S., Yamakawa, K., Valacyclovir and prednisolone treatment for Bell's palsy: A multicenter, randomized, placebo-controlled study (2007) Otol. Neurotol, 28, pp. 408-413
• Strupp, M., Zingler, V.C., Arbuson, V., Niklas, D., Maag, K.P., Dietrich, M., Bense, S., Brandt, T., Methyl-prednisolone, valacyclovir, or the combination for vestibular neuritis (2004) N. Engl. J. Med, 351, pp. 354-361
• Tyler, K.L., Herpes simplex virus infections of the central nervous system: Encephalitis and meningitis, including Mollaret's (2004) Herpes, 11, pp. 57-64
• Kamei, S., Sekizawa, T., Shiota, H., Mizutani, T., Itayama, Y., Takasu, T., Morishima, T., Hirayanagi, K., Evaluation of combination therapy using aciclovir and corticosteroid in adult patients with herpes simplex virus encephalitis (2005) J. Neurol. Neurosurg. Psychiatry, 76, pp. 1544-1549
• Sergerie, Y., Boivin, G., Gosselin, D., Rivest, S., Delayed but not early glucocorticoid treatment protects the host during experimental herpes simplex virus encephalitis in mice (2007) J. Infect. Dis, 195, pp. 817-825
• Fitch, M.T., van de Beek, D., Drug Insight: Steroids in CNS infectious diseases--new indications for an old therapy (2008) Nat. Clin. Pract. Neurol, 4, pp. 97-104
• Erlandsson, A.C., Bladh, L.G., Stierna, P., Yucel-Lindberg, T., Hammarsten, O., Modéer, T., Harmenberg, J., Wikström, A.C., Herpes simplex virus type 1 infection and glucocorticoid treatment regulate viral yield, glucocorticoid receptor and NF-kappaB levels (2002) J. Endocrinol, 175, pp. 165-176
• Daibata, M., Bandobashi, K., Kuroda, M., Imai, S., Miyoshi, I., Taguchi, H., Induction of lytic Epstein-Barr virus (EBV) infection by synergistic action of rituximab and dexamethasone renders EBV-positive lymphoma cells more susceptible to ganciclovir cytotoxicity in vitro and in vivo (2005) J. Virol, 79, pp. 5875-5879
• Ansari, A.W., Schmidt, R.E., Abdul, H.H., Prednisolone mediated suppression of HIV-1 viral load strongly correlates with C-C chemokine CCL2 (2007) In Vivo and In Vitro Findings. Clin. Immunol, 125, pp. 1-4
• Kino, T., Kopp, J.B., Chrousos, G.P., Glucocorticoids suppress human immunodeficiency virus type-1 long terminal repeat activity in a cell type-specific, glucocorticoid receptor-mediated fashion: Direct protective effects at variance with clinical phenomenology (2000) J. Steroid Biochem. Mol. Biol, 75, pp. 283-290
• Reis, S.R., Sampaio, A.L., Henriques, M.G., Gandini, M., Azeredo, E.L., Kubelka, C.F., An in vitro model for dengue virus infection that exhibits human monocyte infection, multiple cytokine production and dexamethasone immunomodulation (2007) Mem. Inst. Oswaldo Cruz, 102, pp. 983-990
• Neves-Souza, P.C., Azeredo, E.L., Zagne, S.M., Valls-de-Souza, R., Reis, S.R., Cerqueira, D.I., Nogueira, R.M., Kubelka, C.F., Inducible nitric oxide synthase (iNOS) expression in monocytes during acute Dengue Fever in patients and during in vitro infection (2005) BMC Infect Dis, 5, p. 64
• Benz, D., Cadet, P., Mantione, K., Zhu, W., Stefano, G., Tonal nitric oxide and health: Anti-bacterial and -viral actions and implications for HIV (2002) Med. Sci. Monit, 8, pp. 27-31
• Nawata, H., Yanase, T., Goto, K., Okabe, T., Ashida, K., Mechanism of action of antiaging DHEA-S and the replacement of DHEA-S (2002) Mech Ageing Dev, 123, pp. 1101-1106
• Labrie, F., Luu-The, V., Labrie, C., Bélanger, A., Simard, J., Lin, S.-X., Pelletier, G., Endocrine and intracrine sources of androgens in women: Inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone (2003) Endocr. Rev, 24, pp. 152-182
• Liu, D., Si, H., Reynolds, K.A., Zhen, W., Jia, Z., Dillon, J.S., Dehydroepiandrosterone protects vascular endothelial cells against apoptosis through a Galphai protein-dependent activation of phosphatidylinositol 3-kinase/Akt and regulation of antiapoptotic Bcl-2 expression (2007) Endocrinology, 148, pp. 3068-3076
• Mulder, J.W., Frissen, P.H., Krijnen, P., Endert, E., de Wolf, F., Goudsmit, J., Masterson, J.G., Lange, J.M., Dehydroepiandroster-one as predictor for progression to AIDS in asymptomatic human immunodeficiency virus-infected men (1992) J. Infect. Dis, 165, pp. 413-418
• Yang, J.Y., Schwartz, A., Henderson, E.E., Inhibition of 3'azido-3'deoxythymidine-resistant HIV-1 infection by dehydroepiandros-terone in vitro (1994) Biochem. Biophys. Res. Commun, 201, pp. 1424-1432
• Henderson, E., Schwartz, A., Pashko, L., Abou-Gharbia, M., Swern, D., Dehydroepiandrosterone and 16 alpha-bromo-epiandrosterone: Inhibitors of Epstein-Barr virus-induced transformation of human lymphocytes (1981) Carcinogenesis, 2, pp. 683-686
• Henderson, E., Yang, J.Y., Schwartz, A., Dehydroepiandrosterone (DHEA) and synthetic DHEA analogs are modest inhibitors of HIV-1 IIIB replication (1992) AIDS Res. Hum. Retroviruses, 8, pp. 625-631
• Yang, J.Y., Schwartz, A., Henderson, E.E., Inhibition of HIV-1 latency reactivation by dehydroepiandrosterone (DHEA) and an analog of DHEA (1993) AIDS Res. Hum. Retroviruses, 9, pp. 747-754
• Bradley, W., Graus, L., Good, R., Day, N., Dehydroepiandrosterone inhibits replication of feline immunodeficiency virus in chronically infected cells (1995) Vet. Immunol. Immunopathol, 46, pp. 159-168
• Chang, C., Ou, Y., Raung, S., Chen, C., Antiviral effect of dehy-droepiandrosterone on Japanese encephalitis virus infection (2005) J. Gen. Virol, 86, pp. 2513-2523
• Romanutti, C., Bruttomesso, A.C., Castilla, V., Bisceglia, J.A., Galagovsky, L.R., Wachsman, M.B., In vitro antiviral activity of dehydroepiandrosterone and its synthetic derivatives against vesicular stomatitis virus (2008) Vet. J, 182, pp. 327-335
• Acosta, E.G., Bruttomesso, A.C., Bisceglia, J.A., Wachsman, M.B., Galagovsky, L.R., Castilla, V., Dehydroepiandrosterone, Epiandrosterone and Synthetic Derivatives Inhibit Junin Virus Replication (2008) In Vitro.Virus Res, 135, pp. 203-212
• Chen, C.J., Raung, S.L., Kuo, M.D., Wang, Y.M., Suppression of Japanese encephalitis virus infection by non-steroidal anti-inflammatory drugs (2002) J. Gen. Virol, 83, pp. 1897-1905
• Shin, Y., Liu, Q., Tikoo, S.K., Babiuk, L.A., Zhou, Y., Effect of the phosphatidylinositol 3-kinase/Akt pathway on influenza A virus propagation (2007) J. Gen. Virol, 88, pp. 942-950
• Jiang, Y., Miyazaki, T., Honda, A., Hirayama, T., Yoshida, S., Tanaka, N., Matsuzaki, Y., Apoptosis and inhibition of the phos-phatidylinositol 3-kinase/Akt signaling pathway in the antiproliferative actions of dehydroepiandreosterone (2005) J.Gastoenterol, 40, pp. 460-497
• Whiting, K.P., Restall, C.J., Brain, P.F., Steroid hormone-induced effects on membrane fluidity and their potential roles in non-genomic mechanisms (2000) Life Sci, 67, pp. 743-757
• Mavoungou, D., Poaty-Mavoungoun, V., Akoume, M., Mavoungou, B., Inhibition of human immunodeficiency virus type-1 (HIV-1) glycoprotein mediated cell-cell fusion by immunor (IM28) (2005) ViRol. J, 2, pp. 2-9
• Simoncini, T., Mannella, P., Fornari, L., Varone, G., Caruso, A., Genazzani, A.R., Dehydroepiandrosterone modulates endotelial nitric oxide síntesis via direct genomic and nongenomic mechanisms (2003) Endocrinology, 144, pp. 3449-3455
• Loria, R.M., Inge, T.H., Cook, S.S., Szakal, A.K., Regelson, W., Protection against acute lethal viral infections with the native steroid dehydroepiandrosterone (DHEA) (1988) J. Med. Virol, 26, pp. 301-314
• Daigle, J., Carr, D.J.J., Androstenediol antagonizes herpes simplex virus type 1-induced encephalitis through the augmentation of type I IFN production (1998) J. Immunol, 160, pp. 3060-3066
• Pedersen, N.C., North, T.W., Rigg, R., Reading, C., Higgins, J., Leutenegger, C., Henderson, G.L., 16alpha-Bromo-epiandrosterone therapy modulates experimental feline immunodeficiency virus viremia: Initial enhancement leading to long-term suppression (2003) Vet. Immunol. Immunopathol, 94, pp. 133-148
• Bajguz, A., Tretyn, A., The chemical characteristic and distribution of brassinosteroids in plants (2003) Phytochemistry, 62, pp. 1027-1046
• Ryu, H., Kim, K., Cho, H., Park, J., Choe, S., Hwang, I., Nucleocy-toplasmic shuttling of BZR1 mediated by phosphorylation is essential in Arabidopsis brassinosteroid signaling (2007) Plant Cell, 19, pp. 2749-2762
• Karlova, R., de Vries, S.C., Advances in understanding brassinos-teroid signaling (2006) Sci. STKE, 354, p. 36
• Dixon, R.A., Natural products and plant disease resistance (2001) Nature, 411, pp. 843-847
• Wachsman, M.B., López, E.M., Ramírez, J.A., Galagovsky, L.R., Coto, C.E., Antiviral effect of brassinosteroids against herpes virus and arenaviruses (2000) Antivir. Chem. Chemother, 11, pp. 71-77
• Wachsman, M.B., Ramirez, J.A., Galagovsky, L.R., Coto, C.E., Antiviral activity of brassinosteroids derivatives against measles virus in cell cultures (2002) Antivir. Chem. Chemother, 13, pp. 61-66
• Talarico, L.B., Ramirez, J.A., Galagovsky, L.R., Wachsman, M.B., Structure-activity relationship studies in a set of new brassinos-teroid derivatives assayed against herpes simplex virus type 1 and 2 in cell cultures (2002) Med. Chem. Res, 11, pp. 434-444
• Wachsman, M.B., Castilla, V., Talarico, L.B., Ramirez, J.A., Galagovsky, L.R., Coto, C.E., Antiherpetic mode of action of (22S, 23S)-3beta-bromo-5alpha, 22, 23-trihydroxystigmastan-6-one in vitro (2004) Int. J. Antimicrob. Agents, 23, pp. 524-526
• Wachsman, M.B., Ramírez, J.A., Talarico, L.B., Galagovsky, L.R., Coto, C.E., Antiviral activity of natural and synthetic brassinos-teroids (2004) Curr. Med. Chem.- Anti-Infective Agents, 3, pp. 163-179
• Kohen, F.F., Gunasekera, M., Cross, S.S., New antiviral sterol disulfate ortho esters from the marine sponge Petrosia weinbergi (1991) J. Org. Chem, 56, pp. 1322-1325
• Comin, M.J., Maier, M.S., Roccatagliata, A.J., Pujol, C.A., Damonte, E.B., Evaluation of the antiviral activity of natural sulfated polyhydroxysteroids and their synthetic derivatives and analogs (1999) Steroids, 64, pp. 335-340
• Arthan, D., Svasti, J., Kittakoop, P., Pittayakhachonwut, D., Tanticharoen, M., Thebtaranonth, Y., Antiviral isoflavonoid sulfate and steroidal glycosides from the fruits of Solanum torvum (2002) Phytochemistry, 59, pp. 459-463
• Talarico, L.B., Castilla, V., Ramirez, J.A., Galagovsky, L.R., Wachsman, M.B., Synergistic in vitro interactions between (22S, 23S)-3beta-bromo-5alpha, 22, 23-trihydroxystigmastan-6-one and acyclovir or foscarnet against herpes simplex virus type 1 (2006) ChemoTherapy, 52, pp. 38-42
• Castilla, V., Larzábal, M., Sgalippa, N.A., Wachsman, M.B., Coto, C.E., Antiviral mode of action of a synthetic brassinosteroid against Junin virus replication (2005) Antiviral Res, 68, pp. 88-95
• Meyer, B.J., de la Torre, J.C., Southern, P.J., (2002) In Arenaviruses: Genomic RNAs Transcription and Replication, 1, pp. 139-158. , Oldstone, M. B. A., Ed.; Springer-Verlag: New York
• Romanutti, C., Castilla, V., Coto, C.E., Wachsman, M.B., Antiviral effect of a synthetic brassinosteroid on the replication of vesicular stomatitis virus in Vero cells (2007) Int. J. Antimicrob. Agents, 29, pp. 311-316
• Khripach, V., Zhabinskii, V., De Groot, A.Twenty years of brassi-nosteroids: Steroidal plant hormones warrant better crops for the XXI century (2000) Ann. Bot, 86, pp. 441-447
• Michelini, F.M., Ramírez, J.A., Berra, A., Galagovsky, L.R., Alché, L.E., In vitro and in vivo antiherpetic activity of three new synthetic brassinosteroid analogues (2004) Steroids, 69, pp. 713-720
• Michelini, F.M., Berra, A., Alché, L.E., The in vitro immuno-modulatory activity of a synthetic brassinosteroid analogue would account for the improvement of herpetic stromal keratitis in mice (2008) J. Steroid Biochem. Mol. Biol, 108, pp. 164-170
• Michelini, F.M., Ramírez, J.A., Berra, A., Galagovsky, L.R., Alché, L.E., Anti-herpetic and anti-inflammatory activities of two new synthetic 22, 23-dihydroxylated stigmastane derivatives (2008) J. Steroid Biochem. Mol. Biol, 111, pp. 111-116
• Ramírez, J.A., Bruttomesso, A.C., Michelini, F.M., Acebedo, S.L., Alché, L.E., Galagovsky, L.R., Syntheses of immunomodulating androstanes and stigmastanes: Comparison of their TNF-alpha inhibitory activity (2007) Bioorg. Med. Chem, 15, pp. 7538-7544
• Li, Y., Wang, L., Li, S., Chen, X., Shen, Y., Zhang, Z., He, H., Hao, X., Seco-pregnane steroids target the subgenomic RNA of alphavirus-like RNA viruses (2007) Proc. Natl. Acad. Sci. U. S. A, 104, pp. 8083-8088
• Chiang, L.C., Ng, L.T., Cheng, P.W., Chiang, W., Lin, C.C., Antiviral activities of extracts and selected pure constituents of Ocimum basilicum (2005) Clin. Exp. Pharmacol. Physiol, 32, pp. 811-816
• Kashiwada, Y., Nagao, T., Hashimoto, A., Ikeshiro, Y., Okabe, H., Cosentino, L.M., Lee, K.H., Anti-AIDS agents 38. Anti-HIV activity of 3-O-acyl ursolic acid derivatives (2000) J. Nat. Prod, 63, pp. 1619-1622
• Lee, J.S., Miyashiro, H., Nakamura, N., Hattori, M., Two new triterpenes from the Rhizome of Dryopteris crassirhizoma, and inhibitory activities of its constituents on human immunodeficiency virus-1 protease (2008) Chem. Pharm. Bull, 56, pp. 711-714
• Yim, E.K., Lee, M.J., Lee, K.H., Um, S.J., Park, J.S., Antiprolif-erative and antiviral mechanisms of ursolic acid and dexametha-sone in cervical carcinoma cell lines (2006) Int. J. Gynecol. Cancer, 16, pp. 2023-2031

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------